Found 5 matching trials
Reduced PCV Dosing Schedules in South African Infants PHASE3 This study will evaluate the immunogenicity of a reduced dosing schedule of...
Show More Location
Chris Hani Baragwanath Academic Hospital
Learn More & Join Trial
Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine PHASE3 This study will evaluate safety, reactogenicity and immunogenicity of GSK B...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants PHASE3 The primary objectives of this study are to evaluate the immunogenicity (an...
Show More Location
Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine (MRCG at LSHTM)
Learn More & Join Trial
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe PHASE3 Primary objective:
This study aimed to demonstrate the non-inferiority of ...
Show More Location
Investigational Site Number : 2031006
Learn More & Join Trial
Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children N/A This study will evaluate the persistence of immunogenicity following a redu...
Show More Location
Chris Hani Baragwanath Academic Hospital - DST/NRF VPD RMPRU
Learn More & Join Trial